Free previewYou're reading the free part of this topic. The rest is included with Clinical.See what's included
Fuchs Endothelial Corneal Dystrophy (FECD) & Pseudophakic Bullous Keratopathy (PBK)
Cornea
1. FECD & Pseudophakic Bullous Keratopathy
Fuchs Endothelial Corneal Dystrophy & Corneal Decompensation
Clinical Analogy - The Leaking Pump
Think of the corneal endothelium as a bilge pump in a boat hull. The corneal stroma is constantly absorbing aqueous humour (hull filling with water). The endothelium actively pumps this fluid back - keeping the hull (stroma) dehydrated, compact and transparent. In FECD, the pumps are genetically defective and slowly fail. In PBK, the pumps are mechanically destroyed (by cataract surgery). In both cases, the hull floods → stromal oedema → bullous keratopathy → pain → blindness.
Corneal Endothelial Anatomy & Physiology
Anatomy
- The corneal endothelium is a single layer of predominantly hexagonal cells on the posterior cornea, containing approximately 500,000 cells in a healthy subject.
- The corneal endothelial cell density is approximately 3,000 cells/mm² in young adults and decreases with age.
- It rests on Descemet's membrane (DM) - the basement membrane of the endothelium.
Descemet's Membrane Layers:
| Layer | Thickness | Notes |
|---|---|---|
| Anterior banded zone | Approximately 3 µm at birth; remains relatively constant. | • Fetal/in utero synthesis. • Contains type VIII collagen + laminin. • Remains relatively constant in Fuchs endothelial corneal dystrophy (FECD). • Guttae are posterior Descemet's membrane excrescences associated with abnormal posterior layers. |
| Posterior non-banded zone | Approximately 3 µm at 20 years → approximately 10 µm by 80 years. | • Postnatal secretion. • Continues throughout life. • Thickened in aging. • In Fuchs endothelial corneal dystrophy (FECD), this layer thins while abnormal additional posterior layers contribute to overall Descemet's membrane thickening. |
| Posterior collagenous layer (PCL) / guttae | Variable | • Abnormal posterior extracellular-matrix and basement-membrane-like material is deposited in Fuchs endothelial corneal dystrophy (FECD). • Guttae are posterior Descemet's membrane excrescences. • Guttae may become buried by later secreted material. |
| Layer | Thickness | Notes |
|---|---|---|
| Anterior banded zone | Approximately 3 µm at birth; remains relatively constant. | • Fetal/in utero synthesis. • Contains type VIII collagen + laminin. • Remains relatively constant in Fuchs endothelial corneal dystrophy (FECD). • Guttae are posterior Descemet's membrane excrescences associated with abnormal posterior layers. |
| Posterior non-banded zone | Approximately 3 µm at 20 years → approximately 10 µm by 80 years. | • Postnatal secretion. • Continues throughout life. • Thickened in aging. • In Fuchs endothelial corneal dystrophy (FECD), this layer thins while abnormal additional posterior layers contribute to overall Descemet's membrane thickening. |
| Posterior collagenous layer (PCL) / guttae | Variable | • Abnormal posterior extracellular-matrix and basement-membrane-like material is deposited in Fuchs endothelial corneal dystrophy (FECD). • Guttae are posterior Descemet's membrane excrescences. • Guttae may become buried by later secreted material. |
Endothelial Physiology - The Pump-Leak Model
Stromal hydration is maintained by a balance between passive leak (aqueous entering stroma) and active pump (sodium-potassium adenosine triphosphatase [Na+/K+-ATPase] and bicarbonate-dependent mechanism moving fluid posteriorly).
- Normal endothelial cell density: 2500–3000 cells/mm²
- Critical threshold: <500 cells/mm² → decompensation likely
- Normal central corneal thickness (CCT): 520–540 µm; the supplied evidence did not establish this as a universal range
- Corneal thickness above 640 µm may indicate oedema; in Fuchs endothelial corneal dystrophy (FECD), thickness above 650 µm was associated with greater than 85% probability of epithelial oedema
- Cells are arrested in the G1 phase and do not typically proliferate in vivo; repair occurs mainly through enlargement and migration of residual cells
- Compensatory hypertrophy (polymegethism) and spread (pleomorphism) delay decompensation
Exam pearl
- The endothelium has compensatory reserve through enlargement and migration of remaining cells.
- Endothelial decompensation occurs when the remaining cells can no longer maintain corneal deturgescence.
- Visual symptoms may also occur earlier from guttae-related light scatter.
- Corneal endothelial pump failure and corneal oedema may occur when endothelial cell density falls below approximately 500 cells/mm²; endothelial cell density should be interpreted with endothelial function and clinical corneal oedema.
2. Fuchs Endothelial Corneal Dystrophy (FECD)
Definition & Epidemiology
- Fuchs endothelial corneal dystrophy (FECD) is a bilateral, slowly progressive, primary corneal endothelial dystrophy characterised by progressive endothelial cell loss, abnormal Descemet membrane (DM) secretion (guttae), and eventual corneal decompensation.
- It is the leading indication for corneal transplantation worldwide.
| Parameter | Details |
|---|---|
| Prevalence | • Approximately 4% of adults older than 40 years in the United States • Higher in women |
| Sex ratio | • Female-to-male ratio: 2.5–3:1 in late-onset disease • Early-onset disease may show a more balanced sex distribution in COL8A2-associated disease, but sex distribution is variable |
| Inheritance | • Autosomal dominant (AD) inheritance with variable penetrance • Trinucleotide repeat expansion in the transcription factor 4 (TCF4) locus • Sporadic disease also occurs |
| Onset | • Late-onset disease is more common and typically presents in the fifth or sixth decade • Early-onset disease is rare and typically presents in the third decade • An earlier variant may present in the first decade |
| Bilateral | • Yes - but often asymmetric |
| Parameter | Details |
|---|---|
| Prevalence | • Approximately 4% of adults older than 40 years in the United States • Higher in women |
| Sex ratio | • Female-to-male ratio: 2.5–3:1 in late-onset disease • Early-onset disease may show a more balanced sex distribution in COL8A2-associated disease, but sex distribution is variable |
| Inheritance | • Autosomal dominant (AD) inheritance with variable penetrance • Trinucleotide repeat expansion in the transcription factor 4 (TCF4) locus • Sporadic disease also occurs |
| Onset | • Late-onset disease is more common and typically presents in the fifth or sixth decade • Early-onset disease is rare and typically presents in the third decade • An earlier variant may present in the first decade |
| Bilateral | • Yes - but often asymmetric |
Genetics
Fuchs endothelial corneal dystrophy (FECD) is genetically heterogeneous, with FECD1–FECD8 loci described in current International Committee for Classification of Corneal Dystrophies (IC3D) nomenclature.
| Gene | Locus | Mutation/Mechanism | Pearls |
|---|---|---|---|
| transcription factor 4 (TCF4) (FECD3) | 18q21.2 | • CTG trinucleotide repeat expansion. • ≥40 repeats confers increased Fuchs endothelial corneal dystrophy risk; >50 repeats was highly specific in the original cohort. • Detected in 51%–79% of largely Caucasian Fuchs endothelial corneal dystrophy cohorts; 79% in the original cohort. | • Most common genetic association. • CUG-repeat RNA foci sequester muscleblind-like (MBNL) proteins, supporting RNA toxicity. |
| SLC4A11 (solute carrier family 4 member 11) (FECD4) | 20p13 | • Heterozygous variants are associated with late-onset Fuchs endothelial corneal dystrophy. • Biallelic mutations cause autosomal-recessive congenital hereditary endothelial dystrophy (CHED). | • Fuchs endothelial corneal dystrophy may be late-onset or, less commonly, early-onset. • Congenital hereditary endothelial dystrophy is congenital and severe. • Linked to impaired ion transport and glutamine metabolism. |
| ZEB1 (zinc finger E-box-binding homeobox 1) (FECD6) | 10p11.2 | • Reported association with Fuchs endothelial corneal dystrophy. • ZEB1 causes autosomal-dominant posterior polymorphous corneal dystrophy (PPCD). | • ZEB1 regulates epithelial–mesenchymal transition. • Its causal role in Fuchs endothelial corneal dystrophy remains unconfirmed. |
| COL8A2 (collagen type VIII alpha 2 chain) | 1p34.3-p32.3 | • Autosomal dominant. • p.Gln455Lys mutation is documented. | • Associated with early-onset Fuchs endothelial corneal dystrophy. • Encodes the alpha-2 subunit of collagen VIII, a component of Descemet membrane (DM). |
| Gene | Locus | Mutation/Mechanism | Pearls |
|---|---|---|---|
| transcription factor 4 (TCF4) (FECD3) | 18q21.2 | • CTG trinucleotide repeat expansion. • ≥40 repeats confers increased Fuchs endothelial corneal dystrophy risk; >50 repeats was highly specific in the original cohort. • Detected in 51%–79% of largely Caucasian Fuchs endothelial corneal dystrophy cohorts; 79% in the original cohort. | • Most common genetic association. • CUG-repeat RNA foci sequester muscleblind-like (MBNL) proteins, supporting RNA toxicity. |
| SLC4A11 (solute carrier family 4 member 11) (FECD4) | 20p13 | • Heterozygous variants are associated with late-onset Fuchs endothelial corneal dystrophy. • Biallelic mutations cause autosomal-recessive congenital hereditary endothelial dystrophy (CHED). | • Fuchs endothelial corneal dystrophy may be late-onset or, less commonly, early-onset. • Congenital hereditary endothelial dystrophy is congenital and severe. • Linked to impaired ion transport and glutamine metabolism. |
| ZEB1 (zinc finger E-box-binding homeobox 1) (FECD6) | 10p11.2 | • Reported association with Fuchs endothelial corneal dystrophy. • ZEB1 causes autosomal-dominant posterior polymorphous corneal dystrophy (PPCD). | • ZEB1 regulates epithelial–mesenchymal transition. • Its causal role in Fuchs endothelial corneal dystrophy remains unconfirmed. |
| COL8A2 (collagen type VIII alpha 2 chain) | 1p34.3-p32.3 | • Autosomal dominant. • p.Gln455Lys mutation is documented. | • Associated with early-onset Fuchs endothelial corneal dystrophy. • Encodes the alpha-2 subunit of collagen VIII, a component of Descemet membrane (DM). |
Exam pearl
- In expansion-positive Fuchs endothelial corneal dystrophy (FECD), an intronic trinucleotide repeat expansion in the transcription factor 4 (TCF4) gene produces toxic repeat RNA, contributing to RNA foci formation, muscleblind-like 1 (MBNL1) sequestration, and abnormal RNA splicing.
- The TCF4 repeat expansion in expansion-positive Fuchs endothelial corneal dystrophy (FECD) causes a similar core RNA gain-of-function toxicity to the dystrophia myotonica protein kinase (DMPK) CTG expansion in myotonic dystrophy type 1, including muscleblind-like 1 (MBNL1) sequestration and abnormal RNA splicing; the tissue-specific consequences differ.
- This is a relevant multiple-choice question (MCQ) linkage.
Free preview ends here
Keep reading Fuchs Endothelial Corneal Dystrophy (FECD) & Pseudophakic Bullous Keratopathy (PBK)
10 more sections are included with the Clinical plan.
- Pathogenesis
- Clinical Features
- Management of FECD
- Pseudophakic Bullous Keratopathy (PBK)
- Common Investigations
- Management Algorithm